IL6 and neoplasm: Furthermore, oxaliplatin treatment enhanced secretion of pro-inflammatory cytokine IL-6 and IFN-γ, synergistically promoting HF-CAR-PMs-induced tumour cells killing (Supplementary Fig. S7C).